n Cardiovascular Journal of South Africa - New amlodipine (Amloc(R) ) product available in South Africa : drug trends in cardiology




Extracted from text ... CARDIOVASCULAR JOURNAL OF SOUTH AFRICA Vol 16, No. 1, January/February 2005 61 Pharma Dynamics, South Africa's fastest- growing genetic pharmaceutical company has recently launched amlodipine maleate (Amloc?) as an alter native to Pfizer's amlodipine besylate (Norvasc?). As amlodipine besylate has a number of years before its patent expires, the introduction of the maleate version creates early economic competition. Supported by bio-equivalence and clinical efficacy studies, amlopidine maleate provides equal amounts of the active ingredient amlopidine, with similar clinical benefits to the originator's product. The 10-mg bioequivalence study is published in the product dossier. Amlodipine maleate has been available throughout Europe ..


Article metrics loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error